Reporting owner · CIK 0001555707

Brown Jim

Visual SEC Form 4 history across 1 companies, 14 transactions and 4 filings.

CEO, PRESCEO & PRESIDENTUSANA HEALTH SCIENCES INC
Open-market mix
Filings4Form 4 records
Buying$00 purchases
Selling$147.4K1 sales
Net value−$147.4KBuys minus sells
Companies12 securities
Most recentMar 03, 2025sale

Latest insider transactions

Form 4 filings from available history. Click any column to sort; click it again to flip the order.

Brown Jim transactions
IDTickerInsiderRoleTypeSharesValueCodeFiledTrans date
#165081USNABrown Jim
CEOPRES
sale5.00k-$14.7MS03/04/202503/03/2025
#163366USNABrown Jim
CEOPRES
grant109k$0A03/03/202502/27/2025
#85623USNABrown Jim
CEOPRES
exercise11.8k$0M02/11/202502/08/2025
#85622USNABrown Jim
CEOPRES
exercise2.82k$0M02/11/202502/08/2025
#85621USNABrown Jim
CEOPRES
withholding5.23k-$16.0MF02/11/202502/08/2025
#85620USNABrown Jim
CEOPRES
exercise11.8k—M02/11/202502/08/2025
#85619USNABrown Jim
CEOPRES
withholding1.25k-$3.84MF02/11/202502/08/2025
#85618USNABrown Jim
CEOPRES
exercise2.82k—M02/11/202502/08/2025
#79494USNABrown Jim
CEOPRES
exercise2.69k$0M02/10/202502/07/2025
#79493USNABrown Jim
CEOPRES
exercise4.26k$0M02/10/202502/06/2025

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at USANA HEALTH SCIENCES INC on Mar 03, 2025 valued at $147,350.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at USANA HEALTH SCIENCES INC on Mar 03, 2025 valued at $147,350.

Review SEC filing

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

9 observations · Feb 6, 2025 – Mar 3, 2025. Window ends at the latest available report, not today.

Selected observation · Mar 3, 202515,716 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Feb 6, 202512,970Feb 10, 2025View transaction
Feb 6, 202511,079Feb 10, 2025View transaction
Feb 7, 202513,772Feb 10, 2025View transaction
Feb 7, 202512,577Feb 10, 2025View transaction
Feb 8, 202515,405Feb 11, 2025View transaction
Feb 8, 202514,150Feb 11, 2025View transaction
Feb 8, 202525,950Feb 11, 2025View transaction
Feb 8, 202520,716Feb 11, 2025View transaction
Mar 3, 202515,716Mar 4, 2025View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Feb 251Mar 25

Net value flow

Buys minus sells

Feb 25
$0
Mar 25
−$147.4K

Transaction texture

Ownership and ticket size

Average P/S size$147.4K
Median P/S size$147.4K
Direct14
Indirect0
Mar 03, 2025sale

Associated companies

Visual map of known reporting history

Brown Jim Insider Activity FAQ

SEC Form 4 context

Who is Brown Jim?

Brown Jim is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001555707.

Which companies has Brown Jim reported transactions for?

USANA HEALTH SCIENCES INC

When was Brown Jim's latest insider buy?

No open-market insider purchase is available for this period.

When was Brown Jim's latest insider sale?

sale at USANA HEALTH SCIENCES INC on Mar 03, 2025 valued at $147,350.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.